US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

39.68

-0.3200-0.80%

Post-market: 39.680.00000.00%17:19 EDT

Volume:614.62K

Turnover:24.43M

Market Cap:1.13B

PE:-20.90

High:40.50

Open:40.00

Low:38.82

Close:40.00

52wk High:41.70

52wk Low:16.54

Shares:28.52M

Float Shares:13.13M

Volume Ratio:1.16

T/O Rate:4.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8984

EPS(LYR):-2.3387

ROE:-26.25%

ROA:-18.44%

PB:5.48

PE(LYR):-16.97

Loading ...

Overview Company News Filings

Arovella Therapeutics Full Year 2025 Earnings: AU$0.007 loss per share (vs AU$0.009 loss in FY 2024)

Simply Wall St.

Arcturus Therapeutics Is Maintained at Outperform by Leerink Partners

Summit Therapeutics put volume heavy and directionally bearish

TD Cowen Sticks to Its Buy Rating for LENZ Therapeutics (LENZ)

Arcturus Therapeutics price target lowered to $54 from $63 at Leerink

IRLAB Therapeutics to Present Q2 2025 Interim Report

Alterity Therapeutics Announces Quotation of New Securities on ASX

Ocumension Therapeutics Logs Lower Losses in H1; Eye Drug Meets Trial Goal

MT Newswires Live

Avenue Therapeutics Reports Positive Earnings Amid Challenges

Major Shareholder Offloads Over a Million Tango Therapeutics Shares!

Cynata Therapeutics Announces Quotation of New Securities

Arovella Therapeutics Releases 2025 Corporate Governance Statement

Akari Therapeutics Cancels Peak Bio Note and Loan

NeuroSense Therapeutics Announces Annual General Meeting for September 2025

BriaCell Therapeutics Says Board Approved Share Consolidation

MT Newswires Live

Dermata Therapeutics Is Maintained at Buy by Maxim Group

Dianthus Therapeutics Is Maintained at Outperform by Wedbush

Keros Therapeutics Shareholder ADAR1 Capital Urges Board to 'Work Collaboratively'

MT Newswires Live

Ocumension Therapeutics Reports Strong Revenue Growth Amid Product Expansion

Lisata Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":39.68,"timestamp":1756152000000,"preClose":40,"halted":0,"volume":614622,"hourTrading":{"tag":"盘后","latestPrice":39.68,"preClose":39.68,"latestTime":"17:19 EDT","volume":4356,"amount":172626.25881600002,"timestamp":1756156769297},"delay":0,"floatShares":13134810,"shares":28522096,"eps":-1.898372,"marketStatus":"Post-Mkt","change":-0.32,"latestTime":"08-25 17:29:59 EDT","open":40,"high":40.5,"low":38.815,"amount":24434171.612490002,"amplitude":0.042125,"askPrice":41,"askSize":50,"bidPrice":39.1,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.898372,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1756166400000},"marketStatusCode":4,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":40,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":40,"latestTime":"09:27 EDT","volume":300800,"amount":12031724.467200002,"timestamp":1756128420047},"postHourTrading":{"tag":"盘后","latestPrice":39.68,"preClose":39.68,"latestTime":"17:19 EDT","volume":4356,"amount":172626.25881600002,"timestamp":1756156769297},"volumeRatio":1.161938,"impliedVol":0.8322,"impliedVolPercentile":0.7263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":13134810,"roa":"-18.44%","roe":"-26.25%","lyrEps":-2.338654,"volumeRatio":1.161938,"shares":28522096,"dividePrice":0,"high":40.5,"amplitude":0.042125,"preClose":40,"low":38.815,"week52Low":16.535,"pbRate":"5.48","psRate":"226.35","week52High":41.7,"institutionHeld":0,"latestPrice":39.68,"committee":-0.666667,"eps":-1.898372,"divideRate":0,"volume":614622,"delay":0,"ttmEps":-1.898372,"open":40,"prevYearClose":28.87,"prevWeekClose":40,"prevMonthClose":29.77,"prevQuarterClose":29.31,"fiveDayClose":38.77,"twentyDayClose":31.51,"sixtyDayClose":29.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-30","symbol":"LENZ","fiscalQuarterEnding":"2025/06","expectedEps":-0.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-08-22","current":-21.691773,"percent":0.002985,"low":-22.268769,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"high":-5.069183,"avg":-11.98188,"sd":4.459531,"marketCap":1136605525},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525}],"updateTime":1756120956215},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561887782","title":"Arovella Therapeutics Full Year 2025 Earnings: AU$0.007 loss per share (vs AU$0.009 loss in FY 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2561887782","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561887782?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:21","pubTimestamp":1755894079,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics ( ASX:ALA ) Full Year 2025 Results Key Financial Results Net loss: AU$7.51m (loss narrowed by 14...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ala/arovella-therapeutics-shares/news/arovella-therapeutics-full-year-2025-earnings-au0007-loss-pe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","ALA.AU"],"gpt_icon":0},{"id":"2561406679","title":"Arcturus Therapeutics Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2561406679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561406679?lang=en_us&edition=fundamental","pubTime":"2025-08-22 23:45","pubTimestamp":1755877500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 22, 2025 11:45 ET (15:45 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ARCT"],"gpt_icon":0},{"id":"2561403008","title":"Summit Therapeutics put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2561403008","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561403008?lang=en_us&edition=fundamental","pubTime":"2025-08-22 22:55","pubTimestamp":1755874509,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Summit Therapeutics (SMMT) with 1,584 puts trading, or 2x expected. Most active are 9/5 weekly 26 puts and Sep-25 19 puts, wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-put-volume-heavy-and-directionally-bearish-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-put-volume-heavy-and-directionally-bearish-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SMMF","LU2488822045.USD","SMMT","BK4539","BK4211","BK4007","LENZ"],"gpt_icon":0},{"id":"2561471383","title":"TD Cowen Sticks to Its Buy Rating for LENZ Therapeutics (LENZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2561471383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561471383?lang=en_us&edition=fundamental","pubTime":"2025-08-22 19:56","pubTimestamp":1755863771,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Stacy Ku maintained a Buy rating on LENZ Therapeutics today and set a price target of $60.00. The company’s shares closed yesterda...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-its-buy-rating-for-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-its-buy-rating-for-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","TD","COWN"],"gpt_icon":0},{"id":"2561471362","title":"Arcturus Therapeutics price target lowered to $54 from $63 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2561471362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561471362?lang=en_us&edition=fundamental","pubTime":"2025-08-22 19:50","pubTimestamp":1755863410,"startTime":"0","endTime":"0","summary":"Leerink analyst Lili Nsongo lowered the firm’s price target on Arcturus Therapeutics (ARCT) to $54 from $63 and keeps an Outperform rating on the s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcturus-therapeutics-price-target-lowered-to-54-from-63-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcturus-therapeutics-price-target-lowered-to-54-from-63-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2561425366","title":"IRLAB Therapeutics to Present Q2 2025 Interim Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2561425366","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561425366?lang=en_us&edition=fundamental","pubTime":"2025-08-22 14:33","pubTimestamp":1755844403,"startTime":"0","endTime":"0","summary":"IRLAB Therapeutics AB Class A ( ($SE:IRLAB.A) ) has shared an announcement. IRLAB Therapeutics AB announced a presentation and webcast for their Q2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-to-present-q2-2025-interim-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-to-present-q2-2025-interim-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2561447041","title":"Alterity Therapeutics Announces Quotation of New Securities on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2561447041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561447041?lang=en_us&edition=fundamental","pubTime":"2025-08-22 12:57","pubTimestamp":1755838633,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Alterity Therapeutics ( ($AU:ATH) ). Alterity Therapeutics Limited has announced the quotation of 1,283,942 ord...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-announces-quotation-of-new-securities-on-asx-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-announces-quotation-of-new-securities-on-asx-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2561426244","title":"Ocumension Therapeutics Logs Lower Losses in H1; Eye Drug Meets Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2561426244","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561426244?lang=en_us&edition=fundamental","pubTime":"2025-08-22 11:58","pubTimestamp":1755835116,"startTime":"0","endTime":"0","summary":"Ocumension Therapeutics  reported 132.3 million yuan in loss for the first half of 2025, narrowing from a loss of 151.3 million yuan a year earlier, according to a Thursday filing with the Hong Kong bourse.Loss per share was 0.17 yuan, compared with 0.23 yuan in the prior year.Revenue at the drug company increased 75% year-on-year to 294 million yuan, figures showed.Meanwhile, in a separate announcement, the company said its OT-301 drug candidate met the main goal of a second late-stage study.The drug was found to be non-inferior to the current standard of care latanoprost in the phase 3 Denali trial of subjects with an eye condition called pen-angle glaucoma or ocular hypertension.As a result, the medicine now meets the requirements for new drug approval in China, the firm said.Ocumension Therapeutics is developing OT-301, also known as NCX 470, with Nicox.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK4007","LENZ","BK4139","01477","BK4539","BK1574"],"gpt_icon":0},{"id":"2561442119","title":"Avenue Therapeutics Reports Positive Earnings Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2561442119","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561442119?lang=en_us&edition=fundamental","pubTime":"2025-08-22 11:57","pubTimestamp":1755835021,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics ( ($ATXI) ) has released its Q2 earnings. Here is a breakdown of the information Avenue Therapeutics presented to its investors...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avenue-therapeutics-reports-positive-earnings-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avenue-therapeutics-reports-positive-earnings-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2561402446","title":"Major Shareholder Offloads Over a Million Tango Therapeutics Shares!","url":"https://stock-news.laohu8.com/highlight/detail?id=2561402446","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561402446?lang=en_us&edition=fundamental","pubTime":"2025-08-22 10:14","pubTimestamp":1755828889,"startTime":"0","endTime":"0","summary":"New insider activity at Tango Therapeutics ( ($TNGX) ) has taken place on August 21, 2025. Significant shareholder Third Rock Ventures IV, L.P. has...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-shareholder-offloads-over-a-million-tango-therapeutics-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-shareholder-offloads-over-a-million-tango-therapeutics-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2561448997","title":"Cynata Therapeutics Announces Quotation of New Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2561448997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561448997?lang=en_us&edition=fundamental","pubTime":"2025-08-22 08:57","pubTimestamp":1755824275,"startTime":"0","endTime":"0","summary":"An update from Cynata Therapeutics Limited ( ($AU:CYP) ) is now available. Cynata Therapeutics Limited has announced the application for quotation ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cynata-therapeutics-announces-quotation-of-new-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cynata-therapeutics-announces-quotation-of-new-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2561410675","title":"Arovella Therapeutics Releases 2025 Corporate Governance Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2561410675","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561410675?lang=en_us&edition=fundamental","pubTime":"2025-08-22 08:09","pubTimestamp":1755821348,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Limited ( ($AU:ALA) ) just unveiled an announcement. Arovella Therapeutics Limited has released its corporate governance stat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arovella-therapeutics-releases-2025-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arovella-therapeutics-releases-2025-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2561116494","title":"Akari Therapeutics Cancels Peak Bio Note and Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2561116494","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561116494?lang=en_us&edition=fundamental","pubTime":"2025-08-22 05:30","pubTimestamp":1755811858,"startTime":"0","endTime":"0","summary":"Akari Therapeutics ( ($AKTX) ) has issued an announcement. Akari Therapeutics has announced a Peak Bio Note and Loan Cancellation Agreement. This a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-cancels-peak-bio-note-and-loan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-cancels-peak-bio-note-and-loan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007","SKIS"],"gpt_icon":0},{"id":"2561419086","title":"NeuroSense Therapeutics Announces Annual General Meeting for September 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2561419086","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561419086?lang=en_us&edition=fundamental","pubTime":"2025-08-22 05:17","pubTimestamp":1755811056,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd. ( ($NRSN) ) has shared an announcement. NeuroSense Therapeutics Ltd. has announced its upcoming Annual General Meeting...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurosense-therapeutics-announces-annual-general-meeting-for-september-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurosense-therapeutics-announces-annual-general-meeting-for-september-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2561497167","title":"BriaCell Therapeutics Says Board Approved Share Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2561497167","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561497167?lang=en_us&edition=fundamental","pubTime":"2025-08-22 01:01","pubTimestamp":1755795668,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics  said Thursday that its board has approved a share consolidation on the basis of one new share for every 10 currently outstanding shares to ensure continued compliance with the listing requirements of The Nasdaq Capital Market.The consolidation is subject to approval by the Nasdaq and the Toronto Stock Exchange, and is expected to become effective on Aug. 25, the company said.Price: 0.66, Change: -0.03, Percent Change: -4.48","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","BK4539","BK4139","BCTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2561449785","title":"Dermata Therapeutics Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2561449785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561449785?lang=en_us&edition=fundamental","pubTime":"2025-08-22 00:41","pubTimestamp":1755794460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 12:41 ET (16:41 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA","LENZ"],"gpt_icon":0},{"id":"2561951604","title":"Dianthus Therapeutics Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2561951604","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561951604?lang=en_us&edition=fundamental","pubTime":"2025-08-21 21:41","pubTimestamp":1755783660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DNTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 09:41 ET (13:41 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"2561934444","title":"Keros Therapeutics Shareholder ADAR1 Capital Urges Board to 'Work Collaboratively'","url":"https://stock-news.laohu8.com/highlight/detail?id=2561934444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561934444?lang=en_us&edition=fundamental","pubTime":"2025-08-21 21:15","pubTimestamp":1755782142,"startTime":"0","endTime":"0","summary":"Keros Therapeutics'  largest stockholder ADAR1 Capital Management said Thursday it would like to \"work collaboratively\" with the board on strategy, capital allocation and potential board changes to unlock value for all shareholders.In an open letter, the shareholder, which holds around 13.3% of Keros' outstanding shares, said it was disappointed that the company's board refused to engage with it directly. ADAR1 also said it is seeking to meet with the company's independent directors as soon as possible.The investment manager urged the Keros board to provide a \"clear and detailed plan\" regarding the planned return of $375 million in excess capital announced on June 9.Although its preference is a collaboration with the board, ADAR1 said it would seek to elect new directors at the company's next annual meeting if the board continued to refuse its invitations to engage.Keros did not immediately reply to a request for comment from MT Newswires.Keros shares were down 1.5% in recent premarket","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4007","BK4539","BK4139","KROS"],"gpt_icon":0},{"id":"2561460387","title":"Ocumension Therapeutics Reports Strong Revenue Growth Amid Product Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2561460387","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561460387?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:11","pubTimestamp":1755778306,"startTime":"0","endTime":"0","summary":"Ocumension Therapeutics ( ($HK:1477) ) just unveiled an update. Ocumension Therapeutics announced a 75.4% increase in revenue for the first half of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocumension-therapeutics-reports-strong-revenue-growth-amid-product-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocumension-therapeutics-reports-strong-revenue-growth-amid-product-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2561642384","title":"Lisata Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2561642384","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561642384?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:29","pubTimestamp":1755775740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LSTA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 07:29 ET (11:29 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":2,"totalSize":324,"code":"91000000","status":"200"}]}}